A pharmaceutical company conducts astudy to evaluate the rel

A pharmaceutical company conducts astudy to evaluate the relationship between length of time taking drug X andsize of tumor. They enlist 2400 patients with the same type of benign tumor whohave been on drug X for varying lengths of time (measured in days). They findthat the longer the patient is on the drug, the smaller the patient’s tumorsize (measured in volume). In fact, they report the results as r(2398) =-.21, with significance of p < .0001. What is your initial perceptionof this information? What are other ways, beyond looking at the p-valuealone, you could use to try to interpret what this outcome of r(2398) =-.21 tells us about the relationship between length of time taking drug X andthe size of the tumor? Support your responses.250words plus reference